Pharmacy Residency Spotlight > Archives
Katherine O’Neal, Pharm.D.
Obesity
Katherine O’Neal just completed her first year residency (PGY-1) in Community Pharmacy Practice with USA Drug and the University of Oklahoma College of Pharmacy. Her research focused on providing weight management services through a community pharmacy and increasing patient knowledge of health risks associated with being obese. Her residency director was Kimberly Crosby, Pharm.D., BCPS, CGP.
She is originally from Lawton, OK and is an alumna of the University of Tulsa where she received her Bachelor of Business Administration in Marketing in 1998 and Masters in Business Administration in 2003. She completed her pharmacy prerequisites at Tulsa Community College and received her Pharm.D. in 2008 from the University of Oklahoma.
Katherine is continuing with the OU College of Pharmacy-Tulsa as a PGY-2 Ambulatory Care Resident. She is working with Drs. Michael Miller, Kimberly Crosby, and Kelly Grober for her PGY-2 research project, which focuses on evaluating health literacy preparedness in the community pharmacy. Her residency director is Michelle Condren, Pharm.D., AE-C, CDE.
Upon completion of her post-graduate residency training, Katherine plans to pursue a clinical faculty appointment within a college of pharmacy.
Michelle Lamb, Pharm.D.
Medication-Induced Bone Loss
Michelle Lamb, finishing a first year residency (PGY-1) in Community Pharmacy Practice with USA Drug and the University of Oklahoma College of Pharmacy, is originally from Houston, Texas. She is an alumna of the Colorado School of Mines where she received a Bachelor of Science in Mechanical Engineering in December, 1998. She completed her prerequisites at Red Rocks Community College in Lakewood, Colorado and graduated with her Pharm.D. in 2008 from the University of Oklahoma.
Michelle will be joining the University of Oklahoma College of Pharmacy-Tulsa as a faculty member in August of 2009. Her research has focused on osteoporosis knowledge and risk reduction in patients at risk for medication-induced bone loss. Other research interests include diabetes, hypertension, dyslipidemia and access to medication and pharmaceutical services for the medically indigent population.
Michelle’s residency program director for the PGY-1 Community Pharmacy Residency is Kimberly Crosby, Pharm.D, BCPS, CGP.
Michelle’s PGY1 residency program director is Kimberly Crosby, Pharm.D, BCPS, CGP.
Rebecca Warren, Pharm.D.
Inappropriate Medication Detection
Rebecca Warren is currently completing a PGY-1 residency in pharmacy practice and will soon begin her PGY-2 specialty pharmacy practice residency in internal medicine at the University of Oklahoma College of Pharmacy. Rebecca is originally from Floydada, Texas and earned her Doctor of Pharmacy degree in 2008 from the School of Pharmacy at Texas Tech University Health Sciences Center.
Currently, Rebecca is conducting research with Toni Ripley, Pharm.D., BCPS (AQ-C) evaluating the clinical utility of the Beers criteria as a means of decreasing the use of potentially inappropriate medications used in the geriatric population. Upon completion of her post-graduate residency training, Rebecca plans to pursue a clinical faculty appointment with a college of pharmacy.
Rebecca’s PGY1 residency program director is Winter Smith, Pharm.D., BCPS.
Emily Gish, Pharm.D.
Pediatric Dosing
Emily Gish, currently a first year resident (PGY-1) in Pharmacy Practice, is originally from Yakima, WA. She is an alumna of Washington State University where she received a Bachelor of Science in Biological Science in 2006 and Pharm.D. in 2008. Emily will be completing a PGY-2 residency in pediatrics next year at the University of Oklahoma College of Pharmacy.
Emily is working with Peter N. Johnson, Pharm.D., BCPS, to evaluate the appropriateness of dosing fentanyl continuous intravenous infusions in overweight pediatric intensive care patients versus a normal weight group. She is also assessing withdrawal rates between groups. Dosing medications management in overweight children is an under-studied area at this time, but hopefully this study will bring more clarity to the dosing requirements of this particular sedative/analgesic agent.
Emily's residency program director for the PGY-1 Pharmacy Residency is Winter Smith, Pharm.D., BCPS.
Russell Benefield, Pharm.D.
HIV
Originally from Sedro-Woolley, Wash., Russell Benefield graduated from the University of Washington with his Bachelor of Science in Biochemistry (2003) and earned a Doctor of Pharmacy degree (2007) from Washington State University. After graduation, Russell was a staff pharmacist for both Yakima Memorial Hospital and Fred Meyer before pursuing residency training. He is now completing his first year pharmacy residency (PGY-1) at the University of Oklahoma College of Pharmacy.
Russell’s practice interests are in HIV and other infectious diseases and he plans to complete a specialty residency in this area after his PGY-1 training. He is currently working with Chris Rathbun, Pharm.D., BCPS, AQ-ID and Michelle Liedtke, Pharm.D. in evaluating the incidence of cardiac conduction abnormalities in HIV-infected patients starting atazanavir. After completion of his post-graduate training, Russell’s plan is to pursue a clinical faculty appointment.
Russell’s residency program director for the PGY-1 Pharmacy Residency is . Winter Smith, Pharm.D., BCPS.
Caroline Johnson, Pharm.D.
Medication Reconciliation
Caroline Johnson is from Duncan, Oklahoma. She studied chemistry at Oklahoma State University in Stillwater, Oklahoma, before being accepted into the Doctor of Pharmacy (Pharm.D.) program at the University of Oklahoma College of Pharmacy in 2004. Caroline received her Pharm.D. in May 2008 and is now completing a post-graduate year one (PGY1) Community Pharmacy Practice Residency at the University of Oklahoma College of Pharmacy.
Caroline’s activities include developing and implementing patient care services in the community pharmacy setting, longitudinal patient care with diabetes and Coumadin patients, as well as dispensing functions at two outpatient pharmacies on the University of Oklahoma Health Sciences Center campus in Oklahoma City. Her current research is in the area of medication reconciliation, which involves comparing a patient’s medication list in a community pharmacy to the patient’s medication list in an electronic medical record (EMR) in order to identify discrepancies between the two sources.
Caroline’s residency program director for the PGY1 Community Practice Residency is Todd Marcy, Pharm.D., BCPS, CDE, CACP.
Teresa Nguyen, Pharm.D.
Diabetes
Teresa Nguyen is from Mustang, Oklahoma. She received her Doctor of Pharmacy degree at the University of Oklahoma in 2007. Teresa completed her post graduate year one (PGY1) pharmacy residency at the Oklahoma City Veteran Affairs Medical Center, and she has now returned to the College of Pharmacy for her post graduate year two (PGY2) residency in Ambulatory Care.
Teresa’s PGY1 research project evaluated the therapeutic effects of formulary conversion from glipizide sustained-release to glipizide immediate-release at the Oklahoma City Veteran Affairs Medical Center. Her current PGY2 research project is a pilot study assessing the need for diabetes self management education in the Vietnamese community of Oklahoma City. Although the prevalence of diabetes is higher in Asian Americans versus non-Hispanic Whites, very little is known about our local, fairly-large, Vietnamese community. Results from this study will hopefully assist health-care agencies and professionals in their efforts to reach out to this community and provide needed services that may not currently be available.
Teresa’s residency program director for the PGY2 Ambulatory Care Pharmacy Residency is Mark Britton, Pharm.D., CDE, BC-ADM.
Tiffany Kessler, Pharm.D.
Internal Medicine
Tiffany Kessler is from Ft. Worth, Texas. In 2007 Tiffany received her Pharm.D. from Southwestern Oklahoma State University in Weatherford, Oklahoma. Having completed her post graduate year one (PGY1) pharmacy residency in 2008 at the University of Oklahoma College of Pharmacy, she is currently conducting her post graduate year two (PGY2) residency in Internal Medicine.
Tiffany’s PGY1 research project evaluated the impact of the FDA black box warning on the prescribing of promethazine in children less than two years of age. Her current PGY2 research project is an education study which aims to evaluate the impact on students’ perspective of an introductory pharmacy practice experience (IPPE) following implementation of structured longitudinal assignments.
Tiffany’s residency program director for the PGY2 Pediatric Pharmacy Residency is Kimi Vesta, Pharm.D.,BCPS
Brooke Honey, Pharm.D.
Pediatrics/Kidney Filtration
Brooke Honey is from Midwest City, Oklahoma. In 2007 Brooke received her Pharm.D. from Southwestern Oklahoma State University in Weatherford, Oklahoma. Having completed her post graduate year one (PGY1) pharmacy residency in 2008 at the University of Oklahoma College of Pharmacy, she is currently conducting her post graduate year two (PGY2) residency in Pediatric Pharmacy Practice.
Brooke’s PGY1 research project evaluated adverse events noted in children receiving continuous infusions of dexmedetomidine in the intensive care unit. Her current PGY2 research project is a pilot study to evaluate the application of the Schwartz equation for predicting renal clearance in overweight children. The primary outcome of the project is to determine the association between the calculated glomerular filtration rate (GFR) via the Schwartz equation with that derived via the 24 hour urine creatinine concentration. Based on the findings of this study, practitioners will be able to make more knowledgeable dosage recommendations for renally eliminated drugs in overweight children.
Brooke’s residency program director for the PGY2 Pediatric Pharmacy Residency is Tracy Hagemann, Pharm.D
Jamie
Miller
Pediatrics/Dosing
Jamie Miller is from Midwest City, Oklahoma. She earned a Bachelor of Science in Biology with a minor in chemistry from Trevecca Nazarene University in Nashville, Tennessee. In 2006, Jamie received her Pharm.D. from Southwestern Oklahoma State University in Weatherford, Oklahoma. She is currently in the process of completing her PGY2 Pediatric Pharmacy Practice Residency at the University of Oklahoma College of Pharmacy. Recently, Jamie received certification as a Board Certified Pharmacotherapy Specialist (BCPS).
Jamie’s current research project involves evaluating medication dosing in overweight pediatric patients. The primary aim of the study is to determine the percent of pediatric patients who are overweight that are admitted to Children's Hospital over a six month period. The secondary aim is to evaluate analgesic and antimicrobial dosing in these patients to determine if overweight patients are at greater risk of receiving inappropriate doses.
Jamie’s residency program director is Tracy Hagemann, Pharm.D.
Craig Trusley
Pharmaceutics
Craig Trusley is from Oklahoma City. He studied chemistry at the University of Portland and the University of Oklahoma before entering the Doctor of Pharmacy program in 2003, and the dual degree program in 2004. In the summer of 2004, Craig completed a research fellowship at the University of Connecticut, and he presented a poster from this work at the Pharmacy Student Research Conference in Denver in summer, 2005.
Craig’s chosen area of specialization is pharmaceutics, and his faculty advisor is Dr. Tom Kupiec, CEO of Analytical Research Laboratories in Oklahoma City. Craig’s thesis research is on the development and validation of a stability indicating high performance liquid chromatography method for deslorelin. He has two published journal articles and has submitted three others for publication, and expects to complete the dual degree in the spring of 2007.
Gautam
Damera
Medicinal Chemistry/Cystic Fibrosis
Gautam Damera is originally from Vizag, India and received his Bachelor of Science degree in Pharmacy from Dr. MGR Medical University in 1997 and his Master of Science degree in Pharmacy from Andhra University in 2000. Gautam entered our Ph.D. program in the Fall of 2000, specializing in medicinal chemistry and cystic fibrosis. Dr. Goverdhan Sachdev is Gautam’s faculty advisor.
Gautam has served as a Graduate Teaching Assistant in the pharmaceutics laboratory for first year pharmacy students. He has three publications in print, and has presented four papers at national meetings. Gautam received an award at the 2005 Graduate Research Education and Technology (GREAT) Symposium for his presentation entitled "Investigation of Airway Mucin and Glycosyltransferase Gene Expression in Chronic Airway Inflammatory Diseases". Gautam has also served as president of the Pharmacy Graduate Student Association (2005).
Gautam expects to complete his Ph.D. degree during the spring semester, 2006. The title of his dissertation is "Molecular mechanisms of mucus hypersecretion in chronic airway obstructive diseases".